FDA confirmed that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Both patients with IPF and patients with PPF treated with nerandomilast demonstrated a smaller decline in forced vital ...

A new preclinical study from Brigham Young University and Unicity International reveals that the dietary supplement Stronghold significantly supports muscle growth and promotes peak body composition.

Detailed price information for Lumentum Holdings (LITE-Q) from The Globe and Mail including charting and trades.

Unfavorable social determinants of health (SDoH) disproportionately affect lung function in non-Hispanic Black and Mexican/Hispanic Americans.

The FDA has broadened the approved use of finerenone (Kerendia) to include treatment for heart failure, according to an ...

AnalySwift high-fidelity modeling software enabled the university to identify optimal configurations for structures including ...

Patients with COPD and type 2 diabetes had a reduced risk for COPD hospitalization, noninvasive positive-pressure ventilation and all-cause mortality if they used an SGLT-2 inhibitor, according to ...

Researchers have removed mitochondria from cells to better study their functions in regulating cell death, differentiation ...

The nine FIs comprise six banks, including Credit Suisse, Citi, Julius Baer and UOB, as well as two capital market services ...

We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...